RNA4Tx provides a continuous‑flow platform for manufacturing RNA therapeutics that eliminates double‑stranded RNA (dsRNA) impurities at the source, removing the need for costly post‑synthesis purification. The fluidics‑based system runs long manufacturing batches, boosting RNA yields per DNA template and lowering production costs. It scales from high‑volume therapeutic manufacturing to small‑scale, personalized RNA treatments, supporting a broadening portfolio of RNA products.
Funding
Funding not disclosed
Founders
Product
Problem
RNA therapeutics often contain double‑stranded RNA (dsRNA) contaminants generated during synthesis, which require expensive and inefficient post‑production purification steps. These purification requirements increase manufacturing costs and limit scalability, especially for personalized or high‑volume treatments.
Solution
RNA4Tx offers a continuous‑flow manufacturing platform that produces RNA molecules while preventing dsRNA formation from the start. The fluidic system runs long, uninterrupted batches, delivering higher RNA yields per DNA template and eliminating the need for downstream purification. By integrating three decades of process expertise, the platform reduces material waste and lowers overall production costs. Its modular design can be scaled to support both large‑volume commercial drug manufacturing and small‑batch personalized therapies, accelerating development timelines for a broad spectrum of RNA‑based products.
Target Audience
Primary customers are pharmaceutical manufacturers and biotech companies developing RNA‑based therapeutics, including both large‑scale commercial producers and organizations focused on personalized medicine.
Features
- Continuous‑flow reactor architecture that synthesizes RNA without generating dsRNA impurities
- Extended run capability that increases RNA yield per DNA template, improving material efficiency
- Elimination of post‑synthesis purification steps, reducing processing time and cost
- Scalable fluidics infrastructure adaptable for high‑volume manufacturing or low‑volume personalized batches
- Integrated process monitoring to maintain product purity and consistency across scale